Royal Bank of Canada Lowers Bausch Health Price Target Amid Market Review
Friday, 2 August 2024, 19:27
Bausch Health Companies Price Target Update
The Royal Bank of Canada has made a significant adjustment to its price target for Bausch Health Companies (NYSE:BHC). The bank has lowered the target from $10.00 to $8.50 amid ongoing evaluations of the company's performance and prospects.
Sector Performance Rating
- The bank has assigned a 'sector perform' rating for Bausch Health.
- This rating suggests the stock is expected to perform in line with the broader market.
- Investors are advised to consider this rating in their strategic planning.
Conclusion
Overall, this adjustment indicates a cautious outlook on Bausch Health, and stakeholders should stay informed as more analysis and updates become available.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.